CIK 0001739104 · Pharmaceutical Preparations (SIC 2834) · NYSE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 4.7 B | 4.4 B | ||
| Net income (USD) | -574.0 M | 68.0 M | ||
| Diluted EPS (USD/shares) | -0.47 | -0.16 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-20 | 4 | 4 | 2026-10-16 |
| 2026-10-20 | 4 | 4 | 2026-10-16 |
| 2026-10-20 | 4 | 4 | 2026-10-16 |
| 2026-10-19 | 4 | 4 | 2026-10-15 |
| 2026-10-15 | 144 | 144 | |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-06 | 4 | 4 | 2026-10-02 |
| 2026-10-01 | 4 | 4 | 2026-09-30 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-09 | 4 | 4 | 2026-09-04 |
| 2026-09-09 | 4 | 4 | 2026-09-04 |
| 2026-09-09 | 4 | 4 | 2026-09-04 |
| 2026-08-25 | 4 | 4 | 2026-08-21 |
| 2026-08-25 | 4 | 4 | 2026-08-21 |
| 2026-08-25 | 4 | 4 | 2026-08-21 |
| 2026-08-21 | 4 | 4 | 2026-08-20 |
| 2026-08-18 | 4 | 4 | 2026-08-18 |
| 2026-08-13 | 4 | 4 | 2026-08-12 |
| 2026-08-10 | 4 | 4 | 2026-08-07 |
| 2026-08-10 | 4 | 4 | 2026-08-07 |
| 2026-08-10 | 4 | 4 | 2026-08-07 |
| 2026-08-10 | 4 | 4 | 2026-08-07 |
Forms on file (last 1,000): 4 663, 8-K 116, 3 43, SC 13G/A 30, 10-Q 24, SC 13G 13, 425 12, SCHEDULE 13G/A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=ELAN (0.002 USD), /gw/filings/filings?ticker=ELAN&form=8-K, /gw/filings/facts?ticker=ELAN&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange